Your browser doesn't support javascript.
loading
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes.
Segerstolpe, Åsa; Palasantza, Athanasia; Eliasson, Pernilla; Andersson, Eva-Marie; Andréasson, Anne-Christine; Sun, Xiaoyan; Picelli, Simone; Sabirsh, Alan; Clausen, Maryam; Bjursell, Magnus K; Smith, David M; Kasper, Maria; Ämmälä, Carina; Sandberg, Rickard.
Afiliação
  • Segerstolpe Å; Department of Cell and Molecular Biology (CMB), Karolinska Institutet, 171 77 Stockholm, Sweden; Integrated Cardio Metabolic Center (ICMC), Karolinska Institutet, 141 57 Huddinge, Sweden.
  • Palasantza A; Department of Cell and Molecular Biology (CMB), Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Eliasson P; Cardiovascular and Metabolic Diseases (CVMD), Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Andersson EM; Cardiovascular and Metabolic Diseases (CVMD), Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Andréasson AC; Cardiovascular and Metabolic Diseases (CVMD), Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Sun X; Department of Biosciences and Nutrition and Center for Innovative Medicine, Novum, Karolinska Institutet, 141 83 Huddinge, Sweden.
  • Picelli S; Ludwig Institute for Cancer Research, 171 77 Stockholm, Sweden.
  • Sabirsh A; Cardiovascular and Metabolic Diseases (CVMD), Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Clausen M; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Bjursell MK; R&D Information (RDI), AstraZeneca, 431 83 Mölndal, Sweden.
  • Smith DM; Discovery Sciences, Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, UK.
  • Kasper M; Department of Biosciences and Nutrition and Center for Innovative Medicine, Novum, Karolinska Institutet, 141 83 Huddinge, Sweden.
  • Ämmälä C; Cardiovascular and Metabolic Diseases (CVMD), Innovative Medicines and Early Development Biotech Unit (iMed), AstraZeneca, 431 83 Mölndal, Sweden.
  • Sandberg R; Department of Cell and Molecular Biology (CMB), Karolinska Institutet, 171 77 Stockholm, Sweden; Integrated Cardio Metabolic Center (ICMC), Karolinska Institutet, 141 57 Huddinge, Sweden; Ludwig Institute for Cancer Research, 171 77 Stockholm, Sweden. Electronic address: rickard.sandberg@ki.se.
Cell Metab ; 24(4): 593-607, 2016 10 11.
Article em En | MEDLINE | ID: mdl-27667667
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Perfilação da Expressão Gênica / Diabetes Mellitus Tipo 2 / Análise de Célula Única Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ilhotas Pancreáticas / Perfilação da Expressão Gênica / Diabetes Mellitus Tipo 2 / Análise de Célula Única Idioma: En Ano de publicação: 2016 Tipo de documento: Article